 |
|
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
|
#
Analysis on the Anti-Cold Medicines in the Latest 3 Years static version printer friendly pdf version
Pharmaceutical Anti-Counterfeiting Strategies static version printer friendly
1 Year - U.S. Regulatory Reporter Newsletter for Addresses in Europe static version printer friendly pdf version
1 Year - U.S. Regulatory Reporter Newsletter for International Address... static version printer friendly
16# static version printer friendly pdf version
200 China-based Best CROs and CMOs static version printer friendly pdf version
2001 Results: Financial Results of the Top 16 Pharmaceutical and Biote... static version printer friendly
2004 HDL CHOLESTEROL - 5th Annual Metabolic Pathways and Drug Targets static version printer friendly
2005 BioMedical Outsourcing Reports Subscription static version printer friendly
2005 Global Biopharmaceutical Outsourcing Directory static version printer friendly pdf version
2005 News in Review: Important Changes for the Pharmaceutical static version printer friendly
2006 Industry Dynamics: Lessons to Be Learned static version printer friendly pdf version
2007 The Worldwide Biochip & Equipment Market static version printer friendly pdf version
2007 The Worldwide Biochip & Equipment Market static version printer friendly pdf version
2007 Trends to Watch: Pharmaceutical Technology static version printer friendly pdf version
2007 U.S. Community Care Facilities for the Elderly Industry Report static version printer friendly pdf version
2007 U.S. Pharmaceutical Preparation Manufacturing Industry Report static version printer friendly pdf version
2007 U.S. Pharmacies & Drug Stores Industry Report static version printer friendly pdf version
2007 Worldwide Drugs and Health and Beauty Aids Product Lines static version printer friendly pdf version
2007 Worldwide Pharmaceutical Preparation Manufacturing Industry Repor... static version printer friendly pdf version
2008 Chartbook of International Pharmaceutical Prices static version printer friendly pdf version
2008 Report for the Investigation of the Chinese Medical and Pharmaceu... static version printer friendly pdf version
2008 U.S. Drugs and Health and Beauty Aids Product Lines static version printer friendly pdf version
2008 U.S. Medicinal & Botanical Manufacturing Industry Report static version printer friendly pdf version
2008 U.S. Pharmaceutical Preparation Mfg. Industry Report static version printer friendly pdf version
2008 U.S. Pharmacies & Drug Stores Industry Report static version printer friendly pdf version
2008 Worldwide Drugs and Health and Beauty Aids Product Lines static version printer friendly pdf version
2008 Worldwide Pharmaceutical Preparation Mfg. Industry Report static version printer friendly pdf version
2008 Worldwide Pharmacies & Drug Stores Industry Report static version printer friendly pdf version
2009 BioMedTracker Outlook Report - Insight Into the Developmental Dru... static version printer friendly pdf version
2009 Chemicals, Pharmaceuticals, Medical Products & Biotechnology - UK... static version printer friendly pdf version
2009 Plimsoll Analysis - Independent Retail Chemists - A comprehensive... static version printer friendly pdf version
2009 Plimsoll Analysis - Pharmaceutical Manufacturers - A comprehensiv... static version printer friendly pdf version
2009 Plimsoll Analysis - Pharmaceutical Wholesalers & Distributors - A... static version printer friendly pdf version
2009 Plimsoll Analysis - Pharmaceuticals - A comprehensive profile of ... static version printer friendly pdf version
2009 Plimsoll Analysis - Retail Chemists - A comprehensive profile of ... static version printer friendly pdf version
2009 Plimsoll Analysis - Scientific & Pharmaceutical Recruitment - A C... static version printer friendly pdf version
2009 Trendology: U.S. Pharmaceutical Preparations Manufacturing static version printer friendly pdf version
2009 Trendology: U.S. Pharmacies & Drug Stores static version printer friendly pdf version
2009 Trends to Watch: Pharmaceutical Technology static version printer friendly pdf version
2009 U.S. Medicinal & Botanical Manufacturing Industry Report static version printer friendly pdf version
2009 U.S. Pharmaceutical Preparation Manufacturing Industry Report static version printer friendly pdf version
2009 U.S. Pharmacies & Drug Stores Industry Report static version printer friendly pdf version
2009 UnitedHealth - Health Insurer Insights static version printer friendly pdf version
2009 Worldwide Pharmaceutical Preparation Mfg. Industry Report static version printer friendly pdf version
2010 U.S. Pharmaceutical Preparation Manufacturing Industry Report static version printer friendly pdf version
2010 U.S. Pharmacies & Drug Stores Industry Report static version printer friendly pdf version
21 Century Strategy of Pharmaceutical Manufacturers 2002 - Japan static version printer friendly
3-Volume Worldwide Pharmaceutical Regulation Series (2002) static version printer friendly pdf version
42nd ICAAC 2002 - Biodefense and Emerging Infections static version printer friendly
5-HT7 antagonists: Novel molecules for the unmet migraine prophylaxis ... static version printer friendly
6th Annual Report and Survey of Biopharmaceutical Manufacturing Capaci... static version printer friendly pdf version
^ Top
A
A Comprehensive Review and Update: What's New in Vascular and Endovasc... static version printer friendly pdf version
A Global Recession Drives New Business Strategies and Evolving Busines... static version printer friendly pdf version
A Guide to Biosimilars, Biogenerics and Follow-On Biologics static version printer friendly pdf version
A Guide to European Union Pharmaceutical Regulations static version printer friendly
A Guide to Fixation and Preservation of Tissues static version printer friendly
A Guide to Good Manufacturing Practices, 3rd Edition static version printer friendly pdf version
A Guide to Pharmaceuticals in the European Union (EU): The Impact of E... static version printer friendly
A Guide To US Reimbursement For Drugs, Medical Devices, and Diagnostic... static version printer friendly
A New Wave of IntraBiotech Alliances: A Company and Therapeutic Market... static version printer friendly
A Practical Guide to Biopharmaceutical Manufacturing static version printer friendly pdf version
Abacavir - Pipeline Developer static version printer friendly pdf version
Abacavir - Pipeline Selector static version printer friendly pdf version
ABC of Arterial and Venous Disease, 2nd Edition static version printer friendly pdf version
ABC of Geriatric Medicine static version printer friendly pdf version
ABC of Transfusion, 4th Edition static version printer friendly pdf version
Acarbose - Pipeline Developer static version printer friendly pdf version
Acarbose - Pipeline Selector static version printer friendly pdf version
Acid Related Gastrointestinal Disorders static version printer friendly
Acitretin - Pipeline Developer static version printer friendly pdf version
Acitretin - Pipeline Selector static version printer friendly pdf version
Actavis Generics Company Intelligence Report static version printer friendly
Acute Medicine: Clinical Cases Uncovered static version printer friendly pdf version
Acute Myeloid Leukemia: Cytarabine Here to Stay static version printer friendly
Adalimumab - Pipeline Developer static version printer friendly pdf version
Adalimumab - Pipeline Selector static version printer friendly pdf version
Adapalene - Pipeline Developer static version printer friendly pdf version
Adapalene - Pipeline Selector static version printer friendly pdf version
Addressing Key Challenges in Drug Safety (Strategic Focus) static version printer friendly pdf version
Addressing Patient Compliance: Targeted marketing driving a shift in f... static version printer friendly
Addressing Pharma’s R&D Productivity Crisis: Technological and Strateg... static version printer friendly
Adefovir - Pipeline Developer static version printer friendly pdf version
Adefovir - Pipeline Selector static version printer friendly pdf version
ADME in Children and The Elderly: Clinical Challenges and Opportunitie... static version printer friendly pdf version
Advanced Life Sciences Cethromycin - Phase III Success Should Allow Me... static version printer friendly pdf version
Advanced Technologies for Optical Networks static version printer friendly pdf version
Advances Imminent in Anti-Angiogenesis Therapeutic static version printer friendly
Advances in Biopharmaceutical Technology in China static version printer friendly pdf version
Advances in Biopharmaceutical Technology in India static version printer friendly pdf version
Advances in Clinical Information Systems--An Impact Analysis static version printer friendly pdf version
Advances in Glasses and Glass-Ceramics static version printer friendly pdf version
Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discov... static version printer friendly pdf version
Advances in the Treatment of Serious Systemic Fungal Infections--An Up... static version printer friendly
Advancing Drug Discovery Through Structure-Guided Drug Design static version printer friendly
Advertising medicines and providing health information on the Internet... static version printer friendly
Airline-related VTE - A Flight of Ideas static version printer friendly
Alendronic Acid & Colecalciferol - Pipeline Developer static version printer friendly pdf version
Alendronic Acid & Colecalciferol - Pipeline Selector static version printer friendly pdf version
Alendronic Acid - Pipeline Developer static version printer friendly pdf version
Alendronic Acid - Pipeline Selector static version printer friendly pdf version
Alfuzosin - Pipeline Developer static version printer friendly pdf version
Alfuzosin - Pipeline Selector static version printer friendly pdf version
Algeria Pharmaceuticals & Healthcare Report Q1 2009 static version printer friendly pdf version
Algeria Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Algeria Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Algeria Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Algeria Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Aliskiren - Pipeline Developer static version printer friendly pdf version
Aliskiren - Pipeline Selector static version printer friendly pdf version
All Change in the US Pharma Market? static version printer friendly pdf version
All India Directory of Pharma Manufacturers static version printer friendly pdf version
Almotriptan - Pipeline Developer static version printer friendly pdf version
Almotriptan - Pipeline Selector static version printer friendly pdf version
Alprazolam - Pipeline Selector static version printer friendly pdf version
Alternative Medicine - Global Outlook static version printer friendly pdf version
Alverine - Pipeline Selector static version printer friendly pdf version
Alzheimer's Disease: Markets, Pipeline and Opportunities 2009 static version printer friendly pdf version
Alzheimer’s and Parkinson’s Diseases - A Global Update of Market Trend... static version printer friendly pdf version
Alzheimers Disease - Beta Treatments On The Horizon static version printer friendly
AmerisourceBergen Business Intelligence Report static version printer friendly pdf version
Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery static version printer friendly pdf version
Amlodipine - Pipeline Selector static version printer friendly pdf version
Amorolfine - Pipeline Developer static version printer friendly pdf version
Amorolfine - Pipeline Selector static version printer friendly pdf version
Amphotericin B - Pipeline Developer static version printer friendly pdf version
Amphotericin B - Pipeline Selector static version printer friendly pdf version
Amyotrophic Lateral Sclerosis: Strategies for Drug Developers static version printer friendly pdf version
An Industry in Crisis: Desperately Seeking New Strategies static version printer friendly pdf version
An Industry in Crisis: Fixing Pharma's Damaged Reputation static version printer friendly pdf version
Analgesics in Colombia static version printer friendly
Analysis of AERS Data on AMD Therapeutics static version printer friendly pdf version
Analysis of AERS Data on Anti-Diabetics static version printer friendly pdf version
Analysis of China Anti-impotence Drug Market static version printer friendly pdf version
Analysis of Chinas Anti-impotence Drug Market static version printer friendly
Analysis of Competitive Strategy for the Japanese Pharmas - Japan static version printer friendly
Analysis of Levofloxacin Market static version printer friendly pdf version
Analysis of the Chinese New Chemical Material Industry static version printer friendly
Analysis of the Levofloxacin Market static version printer friendly
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Targ... static version printer friendly pdf version
Analysis of Top 10 Specialty Pharmaceutical Companies static version printer friendly pdf version
Analysis on Anti-cold Medicines in Recent Three Years static version printer friendly pdf version
Analysis on Chinese Anti-Depression Medicine Market and the Brief Anal... static version printer friendly pdf version
Analysis on the Chinese Anti-Depression Medicine Market and the Brief ... static version printer friendly
Analysis Report of China Anti-HIV Drug Market
static version printer friendly pdf version
Analysis Report of China’s Anti-rheum Drug Market static version printer friendly pdf version
Analysis Report of Chinas Anti-HIV Drug Market static version printer friendly pdf version
Analysis Report on Anti-Gastrohelcosis Medicine Market in China static version printer friendly
Analysis Report on China Antibiotic Industry static version printer friendly pdf version
Analysis Report on China’s Anti-Tumor Medicine Market static version printer friendly
Analysis Report on China’s Antibiotic Market static version printer friendly
Analysis Report on China’s Antineoplastic Market static version printer friendly pdf version
Analysis Report on China’s Ferrous Sulphate & Anti-anemia Medicine Mar... static version printer friendly pdf version
Analysis Report on China’s HBV Medicine Market static version printer friendly
Analysis report on China’s Insulin Market
static version printer friendly pdf version
Analysis Report on China’s Insulin Market static version printer friendly pdf version
Analysis Report on China’s Market of Gynecological External Preparatio... static version printer friendly pdf version
Analysis Report on China’s Metformin & Diabetes Medicine Market static version printer friendly pdf version
Analysis Report on China’s Oral Diabetes Drug Market static version printer friendly pdf version
Analysis Report on China’s Pediatric Medicine Market static version printer friendly pdf version
Analysis Report on China’s Slimming Drug Market
static version printer friendly pdf version
Analysis Report on China’s Slimming Drug Market static version printer friendly pdf version
Analysis Report on China’s Spore Class Antibiotic Market static version printer friendly
Analysis Report on Chinese Anti-Epiphyte Medicine Market static version printer friendly pdf version
Analysis Report on Chinese Anti-Virus Medicine Market static version printer friendly pdf version
Analysis Report on Chinese Medicine Retailing Market static version printer friendly pdf version
Analysis Report on the Blood Fat Capitulating Medicine Market in China... static version printer friendly pdf version
Analysis Report on the Chinese Anti-Epiphyte Medicine Market static version printer friendly
Analysis Report on the Chinese Anti-Virus Medicine Market static version printer friendly
Analysis Report on the Chinese Medicine Retailing Market static version printer friendly pdf version
Analysis Report on the Key Enterprises of VC Manufacturers in China static version printer friendly
Analytical Method Validation and Instrument Performance Verification static version printer friendly pdf version
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascula... static version printer friendly pdf version
Analytical Tool - Hematological Cancers static version printer friendly pdf version
Analytical Tool - Lymphoma Therapeutics & Competitive Insights static version printer friendly
Analytical Tool - The Commercial Success of Cancer Therapeutic Antibod... static version printer friendly
Analytical Tool: Competitive Outlook on HCV static version printer friendly
Analyzing Edible Vaccines static version printer friendly pdf version
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry static version printer friendly pdf version
Analyzing the Global Pharmaceutical Industry static version printer friendly pdf version
Analyzing the Indian Pharmaceutical Industry static version printer friendly pdf version
Analyzing the Major Pharmaceutical Markets static version printer friendly pdf version
Analyzing the Nutraceuticals Market in the UK static version printer friendly pdf version
Anastrozole - Pipeline Developer static version printer friendly pdf version
Anastrozole - Pipeline Selector static version printer friendly pdf version
Angiogenesis Inhibitors and Stimulators - Global Strategic Business Re... static version printer friendly pdf version
Angiogenesis Inhibitors: An Update - Can Iressa and Thalomid Rejuvenat... static version printer friendly
Ankylosing Spondylitis: How Have Biological Therapies Affected the Mar... static version printer friendly pdf version
Annual Death Rate of U.S. Population from Heart Disease, 1950-2008 static version printer friendly pdf version
Annual Death Rate of U.S. Population from Strokes, 1950-2008 static version printer friendly pdf version
Anti-Aging Products - Global Strategic Business Report static version printer friendly
Anti-Obesity Drugs - Global Strategic Business Report static version printer friendly pdf version
Anti-Obesity Drugs - Trends & Opportunities Worldwide static version printer friendly pdf version
Antibacterial Drug Resistance: Expanding Opportunities in the Hospital... static version printer friendly
Antibacterials - Pharma Strikes Antibac static version printer friendly
Antibiotics - Global Strategic Business Report static version printer friendly pdf version
Antibiotics - Global Trends static version printer friendly pdf version
Antibody drug conjugates for cancer treatment: Clinical Trial Pipeline... static version printer friendly pdf version
Antibody Drug Target Atlas in Oncology static version printer friendly pdf version
Antibody Engineering: Technologies, Applications, and Business Opportu... static version printer friendly
Antibody Technology Developments (Technical Insights) static version printer friendly pdf version
Antibody Therapeutics: Product Development, Market Trends, and Strateg... static version printer friendly pdf version
Anticoagulants - A Global Market Review static version printer friendly pdf version
Anticoagulants - Global Strategic Business Report static version printer friendly
Anticonvulsants Market Forecast static version printer friendly pdf version
Antidepressants - Global Strategic Business Report static version printer friendly
Antidepressants Market Forecast static version printer friendly pdf version
Antidiabetics in Australia Market Forecast static version printer friendly pdf version
Antidiabetics Market Forecast static version printer friendly pdf version
Antidyslipidemics - Genericization and Negative Trial Data Drive Marke... static version printer friendly pdf version
Antihypertensives - Two Years to Shape the Market? static version printer friendly
Antihypertensives - Weak Pipeline Leaves Innovation to Novartis static version printer friendly
Antimicrobial resistance: Resistance drives a mature static version printer friendly pdf version
Antithrombotics Market Forecast static version printer friendly pdf version
Antiviral Drugs static version printer friendly pdf version
Antivirals - Global Strategic Business Report static version printer friendly pdf version
Anxiety Disorders - A Decade of Declining Revenues static version printer friendly
Anxiety Disorders - Viable Indication for Antipsychotics Companies static version printer friendly pdf version
Apoptosis 2009: Opportunities in Cancer and Other Diseases static version printer friendly pdf version
Applications of Stem Cells in Drug Discovery static version printer friendly
Aquaculture- Global Technology Developments static version printer friendly pdf version
ARDS: Searching for Effective Therapies static version printer friendly
Are There Changes Ahead for the Generalized Anxiety Disorder Market? static version printer friendly pdf version
Argentina - Pharmaceutical Industry Overview static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Argentina Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Aripiprazole - Pipeline Developer static version printer friendly pdf version
Aripiprazole - Pipeline Selector static version printer friendly pdf version
Armodafinil - Pipeline Developer static version printer friendly pdf version
Armodafinil - Pipeline Selector static version printer friendly pdf version
Arthritis in the United States 2009 static version printer friendly pdf version
ASCOT (The Anglo-Scandinavian Cardiac Outcomes Trial) - BPLA (Blood Pr... static version printer friendly pdf version
Asia Medical Tourism Analysis (2008 – 2013) static version printer friendly pdf version
Asia Pacific Markets for Facial Aesthetics static version printer friendly pdf version
Asia Pacific Markets for Incontinence Devices static version printer friendly pdf version
Asia Pacific Pharma Sector Analysis static version printer friendly pdf version
Asia-Pacific Nutraceuticals static version printer friendly
Asia-Pacific Pharmaceuticals static version printer friendly pdf version
Asia-Pacific Pharmaceuticals Sectors : A Company and Industry Analysis... static version printer friendly pdf version
Asia-Pacific's Growing Role in Global Clinical Trials static version printer friendly pdf version
Asia: Threat or Opportunity? static version printer friendly pdf version
Aspirin Production & Market in China static version printer friendly pdf version
Astellas Pharma: Performance, Products, Pipeline and Potential static version printer friendly pdf version
Asthma and COPD Drug Discoveries: What the Future Holds static version printer friendly pdf version
AstraZeneca: Performance, Capabilities, Goals and Strategies in the Wo... static version printer friendly pdf version
Atopic Dermatitis: Generic Erosion Leads to Stagnant Market static version printer friendly
Atorvastatin - Pipeline Developer static version printer friendly pdf version
Atorvastatin - Pipeline Selector static version printer friendly pdf version
Atovaquone - Pipeline Developer static version printer friendly pdf version
Atovaquone - Pipeline Selector static version printer friendly pdf version
Atrial Fibrillation: Emerging Drug Discovery Targets and Therapeutic C... static version printer friendly pdf version
Attitudes Towards Health & Pharmaceuticals in the United States static version printer friendly
Atypical Antipsychotics: Life-Cycle Management and Future Trends static version printer friendly pdf version
Australia Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Australia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Australian Drug Sector: Sector Report static version printer friendly pdf version
Australian Pharmaceutical Industry: Sector Report static version printer friendly pdf version
Australian Pharmaceutical Sector: Sector Report static version printer friendly pdf version
Australian Pharmaceuticals and Life Sciences IT Market static version printer friendly pdf version
Autoimmune Disease Series: Strategies for Success in the Challenging S... static version printer friendly pdf version
Autoimmune Disease Series: Systemic Sclerosis--Novel Treatment Approac... static version printer friendly pdf version
Autoimmune Disease Therapeutics - Global Strategic Business Report static version printer friendly pdf version
Autoimmune Market Forecast to 2014 static version printer friendly pdf version
Autoimmune Market Outlook to 2012 static version printer friendly pdf version
Automation and Control Solutions in the European Pharmaceutical Market... static version printer friendly pdf version
Avian Influenza static version printer friendly pdf version
Azelaic Acid - Pipeline Selector static version printer friendly pdf version
Azelastine - Pipeline Developer static version printer friendly pdf version
Azelastine - Pipeline Selector static version printer friendly pdf version
Azithromycin - Pipeline Developer static version printer friendly pdf version
Azithromycin - Pipeline Selector static version printer friendly pdf version
^ Top
B
Back Pain Report 2008 static version printer friendly pdf version
Bahrain Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Bahrain Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Bahrain Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Bahrain Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Bangladesh Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Bangladesh Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Bangladesh Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Bangladesh Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Bangladesh Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Barnidipine - Pipeline Developer static version printer friendly pdf version
Barnidipine - Pipeline Selector static version printer friendly pdf version
Barr Pharmaceuticals Busintell Report static version printer friendly
Barriers to Effective Management of Metabolic Syndrome static version printer friendly pdf version
BASF: Performance, Capabilities, Goals and Strategies in the Worldwide... static version printer friendly pdf version
Bayer AG BusIntell Report static version printer friendly
Bayer/Lanxess: Performance, Capabilities, Goals and Strategies in the ... static version printer friendly pdf version
Bayesian Approaches to Clinical Trials and Health-Care Evaluation static version printer friendly
Behavioral Disorders - Opportunities To Shape Future Markets static version printer friendly pdf version
Belarus Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Belarus Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Belarus Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Belgium Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Belgium Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Belgium Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Belgium Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Belgium Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Belgium Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Belgium Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Benchmarking Best Practice at Patent Expiry in Europe - Maximizing Ret... static version printer friendly
Benchmarking Best Practice at Patent Expiry in the US - Maximizing Ret... static version printer friendly pdf version
Benefit-Risk Appraisal of Medicines: A Systematic Approach to Decision... static version printer friendly pdf version
Best Practices for Internal Communications Regarding Brands & Disease ... static version printer friendly pdf version
Best Practices for Post-Marketing Surveillance of Adverse Events withi... static version printer friendly pdf version
Best Practices for Valuing Internal Consulting Organizations static version printer friendly pdf version
Best Practices in Global Pharmaceutical Launches static version printer friendly pdf version
Best Practices in Utilizing Health Outcomes Data for Promotional/Comme... static version printer friendly pdf version
Bevacizumab - Pipeline Developer static version printer friendly pdf version
Bevacizumab - Pipeline Selector static version printer friendly pdf version
Beyond Disease Management: Strategies for Improving Patient Care and C... static version printer friendly pdf version
Beyond Expression Arrays: Emerging Applications for Genomic Microarray... static version printer friendly pdf version
Bicalutamide - Pipeline Developer static version printer friendly pdf version
Bicalutamide - Pipeline Selector static version printer friendly pdf version
Big Pharma Embraces Pharmacogenomics - But Are We There Yet? static version printer friendly pdf version
Big Pharma M&A Analysis to 2012 - Surveying the Growth Rate Landscape static version printer friendly pdf version
Big Pharma Turns to Biologics for Growth to 2010: Financial and Strate... static version printer friendly pdf version
Bigpharma Agreements Handbook 2007 static version printer friendly pdf version
Bigpharma Combined Handbook 2007 static version printer friendly pdf version
Bigpharma Dealmaking Handbook 2007 static version printer friendly pdf version
Bigpharma Partnering Agreements static version printer friendly pdf version
Bimatoprost - Pipeline Developer static version printer friendly pdf version
Bimatoprost - Pipeline Selector static version printer friendly pdf version
Bio-IT report static version printer friendly pdf version
Bio/Pharma R&D Statistical Sourcebook 2009/2010 static version printer friendly pdf version
Bioarrays for Life Science Research, Diagnostics and Drug R&D static version printer friendly pdf version
Biocatalysis for Pharmaceutical Industry: Discovery, Development and M... static version printer friendly pdf version
Biocatalysis for the Pharmaceutical Industry: Discovery, Development, ... static version printer friendly pdf version
Biodisposables: Utility and Technological Advances static version printer friendly pdf version
Bioinformatics Market Update (2006) static version printer friendly pdf version
Biological Dressings, Surgical Sealants and Synthetic Dressings Market... static version printer friendly
Biologics Pipelines: Who Has the Next Promising Monoclonal Antibodies?... static version printer friendly pdf version
Biomarker and Diagnostic Opportunities in Clinical Research for Neurol... static version printer friendly pdf version
Biomarkers - Advanced Technologies and Global Market (2009-2014) static version printer friendly pdf version
Biomarkers - Promising Research, Potential Applications and New Develo... static version printer friendly pdf version
Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Bio... static version printer friendly pdf version
Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and ... static version printer friendly pdf version
Biomed Outsourcing Report-Re-Engineering the Pharmaceutical Company Ou... static version printer friendly
Biomed Outsourcing Report: Competitive Outsourcing Opportunities-China... static version printer friendly pdf version
Biomedical NewsAnalyzer static version printer friendly
Biomedical Optics: Principles and Imaging static version printer friendly pdf version
Biopharma Quarter: Key Trends and Events of the First Quarter of 2009 static version printer friendly pdf version
Biopharma Quarter: Key Trends and Events of the Fourth Quarter of 2008... static version printer friendly pdf version
Biopharma Quarter: Key Trends and Events of the Second Quarter of 2009... static version printer friendly pdf version
Biopharmaceutical Developments--An Emerging Technology Analysis (Techn... static version printer friendly pdf version
Biopharmaceutical Expression Systems and Genetic Engineering Technolog... static version printer friendly pdf version
Biopharmaceuticals in the US and European Markets static version printer friendly pdf version
Bioprocesses of Biopharmaceuticals - The Obligatory Role of Post Trans... static version printer friendly
BioScrip Inc. Business Intelligence Report static version printer friendly
BioScrip Inc. Business Intelligence Report October 2006 static version printer friendly pdf version
Biosimilars (2009 - 2014) static version printer friendly pdf version
Biosimilars and Biobetters: Positioning for a New Market static version printer friendly pdf version
Biosimilars, Biogenerics and Follow-On Biologics static version printer friendly pdf version
Biotech Financing in the Credit Crisis: Strategies for a radically alt... static version printer friendly pdf version
Biotechgate Company Database static version printer friendly pdf version
Biotechnological Innovations in the Pharmaceutical Industry in Poland ... static version printer friendly pdf version
Biotechnological Innovations in the Pharmaceutical Industry in Poland ... static version printer friendly pdf version
Biotransformations in Pharmaceutical Chemistry: Current Reality and Fu... static version printer friendly pdf version
Bisoprolol - Pipeline Developer static version printer friendly pdf version
Bisoprolol - Pipeline Selector static version printer friendly pdf version
Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of... static version printer friendly pdf version
Blockbuster Drugs: A 2005-2014 Forecast static version printer friendly
Blockbuster Patent Expirations and the Future of the Generics Market static version printer friendly pdf version
Blockbuster Pharmaceutical Launches: Establishing Market Leadership static version printer friendly pdf version
Blockbusters Are Alive and Well: Why Their Numbers Continue to Rise static version printer friendly pdf version
Blockbusters going Off-patent - Opportunities for Generic Manufacturer... static version printer friendly pdf version
Blockbusters of the Future: Is the search for new blockbusters a susta... static version printer friendly
Blood and Lymphatic System - Anemia Drug Pipeline Report static version printer friendly pdf version
Blood and Lymphatic System - Dyslipidemia Drug Pipeline Report static version printer friendly pdf version
Blood and Lymphatic System - Electrolyte Deficiencies Drug Pipeline Re... static version printer friendly pdf version
Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders... static version printer friendly pdf version
Blood and Lymphatic System - Hyperlipemia Drug Pipeline Report static version printer friendly pdf version
Blood and Lymphatic System - Myelodysplastic Syndrome Drug Pipeline Re... static version printer friendly pdf version
Blood and Lymphatic System - Thromboembolism Drug Pipeline Report static version printer friendly pdf version
Blood and Lymphatic System Anemia static version printer friendly pdf version
Blood and Lymphatic System Dyslipidemia static version printer friendly pdf version
Blood and Lymphatic System Electrolyte Deficiencies static version printer friendly pdf version
Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders static version printer friendly pdf version
Blood and Lymphatic System Hemorrhage static version printer friendly pdf version
Blood and Lymphatic System Hyperlipemia static version printer friendly pdf version
Blood and Lymphatic System Myelodysplastic Syndrome static version printer friendly pdf version
Blood and Lymphatic System Thromboembolism static version printer friendly pdf version
Booming Pharma Sector in India static version printer friendly pdf version
Bortezomib - Pipeline Developer static version printer friendly pdf version
Bortezomib - Pipeline Selector static version printer friendly pdf version
Bosentan - Pipeline Developer static version printer friendly pdf version
Bosentan - Pipeline Selector static version printer friendly pdf version
Brand Planning for the Pharmaceutical Industry static version printer friendly
Brand-Name and Generic Drug Laboratories in Argentina 2006 static version printer friendly pdf version
Brazil - Pharmaceutical Industry Overview static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Brazil Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Breast Cancer Insight - Defining Drug Decisions - How Can Companies In... static version printer friendly
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race f... static version printer friendly
Brief Report: GM-CSF Antibodies static version printer friendly pdf version
Brief Report: Interleukin-12 (IL-12) and IL-23 Antagonists static version printer friendly pdf version
Brief Report: Interleukin-13 (IL-13) Antibodies static version printer friendly pdf version
Brief Report: Syk Kinase Inhibitors static version printer friendly pdf version
Brimonidine - Pipeline Developer static version printer friendly pdf version
Brimonidine - Pipeline Selector static version printer friendly pdf version
Bringing Physicians Online: Strategies for Europe and the US static version printer friendly
Brinzolamide - Pipeline Developer static version printer friendly pdf version
Brinzolamide - Pipeline Selector static version printer friendly pdf version
Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies ... static version printer friendly pdf version
Budesonide - Pipeline Developer static version printer friendly pdf version
Budesonide - Pipeline Selector static version printer friendly pdf version
Building an Effective Regulatory Relationship with the FDA static version printer friendly pdf version
Building and Sustaining Impactful Competitive Intelligence Organizatio... static version printer friendly pdf version
Building Better Cancer Vaccines: The Progress and Promise of R&D static version printer friendly pdf version
Building on Early Successes of Immunomodulators in the Fight Against C... static version printer friendly pdf version
Building Patient Care Continuity with Prepared Practice Teams, an Audi... static version printer friendly pdf version
Bulgaria - Pharmaceutical Industry Overview static version printer friendly pdf version
Bulgaria Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Bulgaria Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Bulgaria Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Bulgaria Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Bulgaria Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Bulgaria Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Bulk Paclitaxel - A Global Update of Market Trends & Opportunities static version printer friendly pdf version
Bulk Paclitaxel - Global Strategic Business Report static version printer friendly
Buprenorphine - Pipeline Developer static version printer friendly pdf version
Buprenorphine - Pipeline Selector static version printer friendly pdf version
Bupropion - Pipeline Selector static version printer friendly pdf version
Business and Marketing Strategy for China's Pharmaceutical Market static version printer friendly pdf version
Business Intelligence IT Forecast in Pharma through 2012 (Interactive ... static version printer friendly pdf version
Business Opportunities in China: The Impact of the WTO – 2nd Edition static version printer friendly
Business Strategies Of Pharma Makers From Central And Eastern Europe 2... static version printer friendly pdf version
Business Trends: Pharmaceutical Technology - Understanding your Life S... static version printer friendly pdf version
Byetta Case Study: Using Medical Education as a Springboard for Produc... static version printer friendly pdf version
^ Top
C
Cabergoline - Pipeline Developer static version printer friendly pdf version
Cabergoline - Pipeline Selector static version printer friendly pdf version
Calcipotriol - Pipeline Developer static version printer friendly pdf version
Calcipotriol - Pipeline Selector static version printer friendly pdf version
Calcitonin - Pipeline Selector static version printer friendly pdf version
Calcitriol - Pipeline Selector static version printer friendly pdf version
Call Centers in the Pharmaceutical Industry: Hosted and Virtual Hosted... static version printer friendly pdf version
Cambrex: Performance, Capabilities, Goals and Strategies in the Worldw... static version printer friendly pdf version
Can a New Antidepressant Establish Itself in a Highly Competitive Mark... static version printer friendly pdf version
Can Biomarkers Increase R&D Productivity? static version printer friendly pdf version
Can Pathway-Based Approaches Overcome the Problems of Target-Based Dru... static version printer friendly
Can the Use of Biomarkers as Surrogate End Points Stimulate the Drug-D... static version printer friendly pdf version
Canada Pharmaceutical Industry static version printer friendly pdf version
Canada Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Canada Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Canada's Pharmaceutical Industry - Porter's Five Forces Strategy Analy... static version printer friendly pdf version
Canadian Drug Sector: Industry Profile static version printer friendly pdf version
Canadian Pharmaceutical Industry: Sector Report static version printer friendly pdf version
Canadian Pharmaceutical Sales Management static version printer friendly pdf version
Canadian Pharmaceutical Sector: Industry Profile static version printer friendly pdf version
Cancer Drug Discoveries: What the Future Holds: Colorectal Cancer Chap... static version printer friendly pdf version
Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapte... static version printer friendly pdf version
Cancer Drug Discoveries: What the Future Holds: Renal Cancer Chapter static version printer friendly pdf version
Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market Opportu... static version printer friendly pdf version
Cancer Therapeutics 2006: Market Dynamics and R&D Trends static version printer friendly
Candesartan - Pipeline Developer static version printer friendly pdf version
Candesartan - Pipeline Selector static version printer friendly pdf version
Capecitabine - Pipeline Developer static version printer friendly pdf version
Capecitabine - Pipeline Selector static version printer friendly pdf version
Carbohydrate-Based Vaccines and Immunotherapies static version printer friendly pdf version
Carbon Nanotubes: Angels or Demons? static version printer friendly pdf version
Carcinoembryonic Antigen (CEA) Antibodies static version printer friendly pdf version
Caremark Rx Business Intelligence Report 2007 static version printer friendly pdf version
Carprofen (Vet) - Pipeline Developer static version printer friendly pdf version
Carprofen (Vet) - Pipeline Selector static version printer friendly pdf version
Carvedilol - Pipeline Developer static version printer friendly pdf version
Carvedilol - Pipeline Selector static version printer friendly pdf version
Caspofungin - Pipeline Developer static version printer friendly pdf version
Caspofungin - Pipeline Selector static version printer friendly pdf version
Cefditoren - Pipeline Developer static version printer friendly pdf version
Cefditoren - Pipeline Selector static version printer friendly pdf version
Cefprozil - Pipeline Developer static version printer friendly pdf version
Cefprozil - Pipeline Selector static version printer friendly pdf version
Ceftiofur (Vet) - Pipeline Developer static version printer friendly pdf version
Ceftiofur (Vet) - Pipeline Selector static version printer friendly pdf version
Cefuroxime - Pipeline Developer static version printer friendly pdf version
Cefuroxime - Pipeline Selector static version printer friendly pdf version
Celecoxib - Pipeline Developer static version printer friendly pdf version
Celecoxib - Pipeline Selector static version printer friendly pdf version
Cell Signal Inhibitors: A New Generation of Prophylactic Agents static version printer friendly pdf version
Central and Core Laboratories static version printer friendly pdf version
Central and Eastern Europe: Outsourcing Trends and Growth Opportunitie... static version printer friendly pdf version
CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology static version printer friendly pdf version
Cetuximab - Pipeline Developer static version printer friendly pdf version
Cetuximab - Pipeline Selector static version printer friendly pdf version
CFR/ICH GCP Clinical Trial Reference Guide 2009 static version printer friendly pdf version
Challenges in Patient Recruitment for Clinical Trials: Overcoming the ... static version printer friendly
Change Is Percolating Through Japan's Pharmaceutical Markets static version printer friendly pdf version
Changing Market Dynamics Fuel the Evolution of Specialty Pharma static version printer friendly
Changing Role of Medicare and its Impact on Pharmaceutical Industry static version printer friendly pdf version
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer... static version printer friendly
Chile Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Chile Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Chile Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Chile Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Chile Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Chile Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Chile Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Chilie - Pharmaceutical Industry Overview static version printer friendly pdf version
China - Pharmaceutical Industry Overview static version printer friendly pdf version
China Allergy Drug Market Report 2008 static version printer friendly pdf version
China Anesthesia Apparatus Market Report, 2008 static version printer friendly pdf version
China Anti-Cancer Drug Market Report 2008 static version printer friendly pdf version
China Anti-Diabetic Drug Market Report 2008 static version printer friendly pdf version
China Antibiotic Market Report, 2008-2009 static version printer friendly pdf version
China Antibiotic Market Report, 2008-2009 static version printer friendly pdf version
China Antibodies static version printer friendly pdf version
China Biopharmaceutical Industry Report, 2007-2008 static version printer friendly pdf version
China Biopharmaceutical Industry Report, 2007-2008 static version printer friendly pdf version
China Chemical Pharmaceutical Industry Report, 2007 static version printer friendly pdf version
China Chemical Pharmaceutical Industry Report, 2007 static version printer friendly pdf version
China City Commercial Bank Report, 2009 static version printer friendly pdf version
China Contract Research Organization (CRO) Market static version printer friendly pdf version
China Dermatosis Drug Market Report 2008 static version printer friendly pdf version
China Executive Summary of the Chinese Hospital Drug Utilization Volum... static version printer friendly pdf version
China HealthCare & Pricing System Reform 2008 static version printer friendly pdf version
China Hypertension Drug Market 2008 static version printer friendly pdf version
China Industry Research and Investment Analysis: Chinese Patent Drug P... static version printer friendly pdf version
China Industry Research and Investment Analysis: Chinese Patent Drug P... static version printer friendly pdf version
China Medicine and Environmental Protection Industry Newsletters 2003 static version printer friendly
China Membrane Market Report, 2007-2008 static version printer friendly pdf version
China Pharma Outsourcing Annual Review 2009 static version printer friendly pdf version
China Pharma Outsourcing Market By 2015 static version printer friendly pdf version
China Pharmaceutical & Biotechnology Monthly static version printer friendly pdf version
China Pharmaceutical Chain Industry Report 2006 static version printer friendly pdf version
China Pharmaceutical Chain Industry Report, 2006 static version printer friendly pdf version
China Pharmaceutical Chain Industry Report, 2007-2008 static version printer friendly pdf version
China Pharmaceutical Chain Industry Report, 2007-2008 static version printer friendly pdf version
China Pharmaceutical Chain Industry Report, 2009 static version printer friendly pdf version
China Pharmaceutical Chain Industry Report, 2009 static version printer friendly pdf version
China Pharmaceutical Guidebook: Latest Chinese Regulations for Importe... static version printer friendly pdf version
China Pharmaceutical Industry Report (Merger and Reorganization) 2006-... static version printer friendly pdf version
China Pharmaceutical Industry Report (Merger and Reorganization), 2006... static version printer friendly pdf version
China Pharmaceutical Industry: Analysis and Market Trends static version printer friendly pdf version
China Pharmaceutical Logistics Industry Report, 2008 static version printer friendly pdf version
China Pharmaceutical Logistics Industry Report, 2008 static version printer friendly pdf version
China Pharmaceutical Logistics Industry Report, 2009 static version printer friendly pdf version
China Pharmaceutical Logistics Industry Report, 2009 static version printer friendly pdf version
China Pharmaceutical Market Report 2009 static version printer friendly pdf version
China Pharmaceutical Regulatory Report 2008 (with appendix) static version printer friendly pdf version
China Pharmaceutical Regulatory Report 2009 (W/Appendix) static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
China Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
China Product Registration and Regulatory Issues static version printer friendly pdf version
China Retail Pharmacies static version printer friendly pdf version
China Vaccine 2008 static version printer friendly pdf version
China Vaccine Industry Report, 2008-2009 static version printer friendly pdf version
China Vaccine Industry Report, 2008-2009 static version printer friendly pdf version
China's Biopharmaceutical Industry Study, 2005-2006 static version printer friendly
China's Drug Practices and Policies static version printer friendly pdf version
China's Drug Practices and Policies: Regulating Controlled Substances ... static version printer friendly pdf version
China's Guidebook for Pharmaceutical Patent Protection static version printer friendly pdf version
China's Pharmaceutical Industry - Porter's Five Forces Strategy Analys... static version printer friendly pdf version
China's Pharmaceutical Industry - Porter's Five Forces Strategy Analys... static version printer friendly pdf version
China: A New Era of Innovation in Drug Development static version printer friendly pdf version
China’s Attraction and Strategies to Work with It: Analysis of Best St... static version printer friendly pdf version
Chinese Diabetes Treatment Markets static version printer friendly pdf version
Chinese Drug Industry: Sector Report static version printer friendly pdf version
Chinese Drug Sector: Sector Report static version printer friendly pdf version
Chinese Markets for Allergy Drugs static version printer friendly pdf version
Chinese Markets for Alzheimer Disease Drugs static version printer friendly pdf version
Chinese Markets for Anti Peptic Ulcer Drugs static version printer friendly pdf version
Chinese Markets for Anti-Dermatomycosis Skin Drugs static version printer friendly pdf version
Chinese Markets for Anti-Obesity Drugs static version printer friendly pdf version
Chinese Markets for Antibiotics static version printer friendly pdf version
Chinese Markets for Arthritis Treatment Drugs static version printer friendly pdf version
Chinese Markets for Asthma Treatment Drugs static version printer friendly pdf version
Chinese Markets for Biopharmaceuticals static version printer friendly pdf version
Chinese Markets for Blood Disease Drugs static version printer friendly pdf version
Chinese Markets for Diabetes Drugs static version printer friendly pdf version
Chinese Markets for Hepatitis Treatment Drugs static version printer friendly pdf version
Chinese Markets for Hypertension Drugs static version printer friendly pdf version
Chinese Markets for Incretion Drugs static version printer friendly pdf version
Chinese Markets for Insulin static version printer friendly pdf version
Chinese Markets for Mental Illness Drugs static version printer friendly pdf version
Chinese Markets for Osteoporosis Drugs static version printer friendly pdf version
Chinese Markets for Pain and Fever Relief Drugs static version printer friendly pdf version
Chinese Markets for Penicillin static version printer friendly pdf version
Chinese Markets for Pharmaceutical Packaging static version printer friendly pdf version
Chinese Markets for Pharmaceuticals 2005 static version printer friendly
Chinese Pharmaceutical Industry: Sector Report static version printer friendly pdf version
Chinese Pharmaceutical Industry: Strategies, Trends and Opportunities static version printer friendly
Chinese Pharmaceutical Market Overview - Regulatory Reform and the Evo... static version printer friendly pdf version
Chinese Pharmaceutical Market Sales, 2000-2010 static version printer friendly pdf version
Chinese Pharmaceutical Sector: Sector Report static version printer friendly pdf version
Chiral Separation Techniques: A Practical Approach static version printer friendly pdf version
Chiral Technology - International Technology & Market Trends static version printer friendly pdf version
Chirality in Drug Research static version printer friendly pdf version
Chronic Myeloid Leukemia - Gleevec resistance is opening a market for ... static version printer friendly
Chronic Obstructive Pulmonary Disease (COPD) Market: An Analysis static version printer friendly pdf version
Chronic Obstructive Pulmonary Disease (Copd) Update - Considerable Unm... static version printer friendly
Chronic Organ Transplant Rejection: Opportunities Await Improved Thera... static version printer friendly pdf version
Ciclosporin (Vet) - Pipeline Developer static version printer friendly pdf version
Ciclosporin (Vet) - Pipeline Selector static version printer friendly pdf version
Ciclosporin - Pipeline Developer static version printer friendly pdf version
Ciclosporin - Pipeline Selector static version printer friendly pdf version
Ciprofloxacin - Pipeline Developer static version printer friendly pdf version
Ciprofloxacin - Pipeline Selector static version printer friendly pdf version
Cis-trans Isomerization in Biochemistry static version printer friendly pdf version
Cisatracurium - Pipeline Developer static version printer friendly pdf version
Cisatracurium - Pipeline Selector static version printer friendly pdf version
Citalopram - Pipeline Developer static version printer friendly pdf version
Citalopram - Pipeline Selector static version printer friendly pdf version
Cladribine - Pipeline Developer static version printer friendly pdf version
Cladribine - Pipeline Selector static version printer friendly pdf version
Clariant: Performance, Capabilities, Goals and Strategies in the World... static version printer friendly pdf version
Clarithromycin - Pipeline Developer static version printer friendly pdf version
Clarithromycin - Pipeline Selector static version printer friendly pdf version
Classical and Adaptive Clinical Trial Designs Using ExpDesign Studio static version printer friendly pdf version
Clinical Guide to the Diagnosis and Treatment of Mental Disorders static version printer friendly
Clinical Laboratory Testing Market Overview 2006 static version printer friendly pdf version
Clinical Laboratory Testing Market Report: 2009 Edition static version printer friendly pdf version
Clinical Management of Obesity (Technical Insights) static version printer friendly pdf version
Clinical Physiology and Pharmacology: The Essentials static version printer friendly pdf version
Clinical Proteomics: Rethinking Approaches to Protein Biomarker Discov... static version printer friendly pdf version
Clinical Research Outsourcing and India static version printer friendly pdf version
Clinical Stage Partnering Agreements in Biopharma static version printer friendly pdf version
Clinical Trial Design in Women's Health: The Increasing Importance of ... static version printer friendly
Clinical Trial Excellence: Toolkit for Winning Investigators in a Comp... static version printer friendly pdf version
Clinical Trial Supply static version printer friendly pdf version
Clinical Trials and New Drug Developments 1999 - Japan static version printer friendly
Clinical Trials Handbook static version printer friendly pdf version
Clinicas Guide to Early-Stage Medtech Companies static version printer friendly pdf version
Clinicas Medical Device and Diagnostic Company League Tables 2006 static version printer friendly pdf version
Clobetasol - Pipeline Selector static version printer friendly pdf version
Clonazepam - Pipeline Selector static version printer friendly pdf version
Clopidogrel - Pipeline Developer static version printer friendly pdf version
Clopidogrel - Pipeline Selector static version printer friendly pdf version
CMS' New Voluntary Physician Pay-for-Performance Program: Identifying ... static version printer friendly
CNS Therapeutics - Global Strategic Business Report static version printer friendly pdf version
Co-promotion and Co-marketing Agreements in Biopharma, 2nd Edition static version printer friendly pdf version
Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Anal... static version printer friendly pdf version
Cognitive Impairment In Schizoaffective Disorder - Inevitable Or Treat... static version printer friendly
Cold, Cough Allergy in Austria static version printer friendly
Cold, Cough Allergy in Belgium static version printer friendly
Cold, Cough Allergy in Brazil static version printer friendly
Cold, Cough Allergy in Bulgaria static version printer friendly
Cold, Cough Allergy in Canada static version printer friendly
Cold, Cough Allergy in China static version printer friendly
Cold, Cough Allergy in Czech Republic static version printer friendly pdf version
Cold, Cough Allergy in Finland static version printer friendly pdf version
Cold, Cough Allergy in Germany static version printer friendly pdf version
Cold, Cough Allergy in Hungary static version printer friendly pdf version
Cold, Cough Allergy in Indonesia static version printer friendly pdf version
Cold, Cough Allergy in Israel static version printer friendly
Cold, Cough Allergy in Italy static version printer friendly
Cold, Cough Allergy in Malaysia static version printer friendly
Cold, Cough Allergy in Poland static version printer friendly
Cold, Cough Allergy in Romania static version printer friendly
Cold, Cough Allergy in Russia static version printer friendly
Cold, Cough Allergy in Saudi Arabia static version printer friendly
Cold, Cough Allergy in Singapore static version printer friendly
Cold, Cough Allergy in Sweden static version printer friendly
Cold, Cough Allergy in Ukraine static version printer friendly
Cold, Cough Allergy in United Kingdom static version printer friendly
Collagen and HA-Based Biomaterials - Global Strategic Business Report static version printer friendly
Colombia Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Colombia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Colony Stimulating Factors - Current Market Dynamics & Future Outlook static version printer friendly pdf version
Commerce de Detail de Produits Pharmaceutiques en France - Analyse de ... static version printer friendly pdf version
Commercial And Pipeline Insight: ADHD - Immature Adult Market Continue... static version printer friendly pdf version
Commercial and Pipeline Insight: Opioids - Short Acting and Anti-abuse... static version printer friendly pdf version
Commercial and Pipeline Insight: Systemic Antifungals static version printer friendly pdf version
Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Le... static version printer friendly
Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Bio... static version printer friendly
Commercial and Pipeline Perspectives: Upper GI Disorders - Life Cycle ... static version printer friendly pdf version
Commercial and Stakeholder Perspectives: Allergic Rhinitis - Is There ... static version printer friendly
Commercial Insight: ADHD - Strattera Reigns Supreme as Branded Stimula... static version printer friendly
Commercial Insight: Antibacterials - Pharma Strikes Antibac static version printer friendly
Commercial Insight: Antibacterials - Regulations, Resistance & Generic... static version printer friendly pdf version
Commercial Insight: Anticonvulsants - How to Avoid a Brand Identity Cr... static version printer friendly pdf version
Commercial Insight: Anticonvulsants - Non-epilepsy Label Expansions Pr... static version printer friendly pdf version
Commercial Insight: Antidepressants - Novel Mechanism Offers Hope in D... static version printer friendly pdf version
Commercial Insight: Antidepressants - Sliding SSRI Revenues Inevitable... static version printer friendly
Commercial Insight: Antidiabetics - DPP-IV Inhibitors Poised to Sweep ... static version printer friendly pdf version
Commercial Insight: Antidiabetics in Australia - Reimbursement Status ... static version printer friendly pdf version
Commercial Insight: Antidyslipidemics - Statins Hit the Brakes on Mark... static version printer friendly
Commercial Insight: Antihypertensives - Can Manufacturers Maintain Val... static version printer friendly pdf version
Commercial Insight: Antihypertensives - New Challenges for a Maturing ... static version printer friendly pdf version
Commercial Insight: Antipsychotics - From Blockbuster Brands to Billio... static version printer friendly
Commercial Insight: Antithrombotics - Market Expands as Disease Manage... static version printer friendly pdf version
Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Play... static version printer friendly
Commercial Insight: Asthma and COPD - Control is the Goal static version printer friendly
Commercial Insight: Cytotoxics - Generic Adversity Facing Major Cytoto... static version printer friendly
Commercial Insight: HIV - From the Naïve to the Complex static version printer friendly
Commercial Insight: HIV - Reshaping Treatment Paradigms static version printer friendly pdf version
Commercial Insight: Migraine - A Painful Future for the Triptans? static version printer friendly
Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Co... static version printer friendly
Commercial Insight: Parkinson's Disease - Japan and Europe to Drive To... static version printer friendly pdf version
Commercial Insight: Parkinsons Disease - Increased Focus on Earlier Tr... static version printer friendly
Commercial Insight: Transplantation static version printer friendly
Commercial Insight: Vaccines - Reaching Adulthood static version printer friendly
Commercial Opportunities for Enzyme Technologies, 3rd Edition static version printer friendly pdf version
Commercial Opportunities From An Aging Population: Epidemiology, Marke... static version printer friendly
Commercial Perspectives: Anti-dyslipidemics - A tale of two launches static version printer friendly pdf version
Commercial Perspectives: Anti-Hormonals - Tamoxifen to be Obsolete by ... static version printer friendly
Commercial Perspectives: Cytotoxics - Third-Generation Cytotoxics To O... static version printer friendly pdf version
Commercial Perspectives: Fluoroquinolones - Established Products Drive... static version printer friendly
Commercial Perspectives: Hepatitis B and C - The Chinese Way? static version printer friendly
Commercial Perspectives: Pegylated Interferons - Leading the Way in HC... static version printer friendly
Commercial Perspectives: US Hip and Knee Replacement - Market surges i... static version printer friendly pdf version
Commercial Perspectives: Vaccines - Nosocomial Pathogens static version printer friendly pdf version
Common Drug Review Tracker 2008 Annual Report - Premier Package static version printer friendly pdf version
Common Drug Review Tracker 2008 Annual Report - Standard static version printer friendly pdf version
Companion Biomarkers in Drug Development static version printer friendly pdf version
Company Analysis - Glenmark Pharmaceuticals Ltd. static version printer friendly pdf version
Company Study of Huadong Medicine static version printer friendly pdf version
Company Study of Huadong Medicine static version printer friendly pdf version
Comparison of Pharma Outsourcing between China and India static version printer friendly pdf version
Compatibility of Pharmaceutical Solutions and Contact Materials: Safet... static version printer friendly pdf version
Competition Law and Intellectual Property Strategy in Pharmaceuticals ... static version printer friendly pdf version
Competitive Intelligence Policies, Ethics and Data Collection: Navigat... static version printer friendly pdf version
Competitive Profiling of Market Participants in Lifesciences-IT static version printer friendly pdf version
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: Antibody-Drug Conjugates (ADC) static version printer friendly pdf version
Competitor Analysis: Aurora Kinase Inhibitors static version printer friendly pdf version
Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors static version printer friendly pdf version
Competitor Analysis: Coagulation Factors static version printer friendly pdf version
Competitor Analysis: EGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: Elastase Inhibitors static version printer friendly pdf version
Competitor Analysis: EpCAM Antagonists static version printer friendly pdf version
Competitor Analysis: FGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assist... static version printer friendly pdf version
Competitor Analysis: HDAC Inhibitors static version printer friendly pdf version
Competitor Analysis: Her2 Receptor Antagonists static version printer friendly pdf version
Competitor Analysis: IGF-1R Antagonists static version printer friendly pdf version
Competitor Analysis: Immunocytokines static version printer friendly pdf version
Competitor Analysis: Immunotoxins static version printer friendly pdf version
Competitor Analysis: Interleukin-1 (IL-1) and Receptor (IL-1R) Antagon... static version printer friendly pdf version
Competitor Analysis: MEK Inhibitors static version printer friendly pdf version
Competitor Analysis: Muscarinic Receptor Agonists & Antagonists static version printer friendly pdf version
Competitor Analysis: Novel Mitotic Kinase Inhibitors static version printer friendly pdf version
Competitor Analysis: Obesity static version printer friendly pdf version
Competitor Analysis: Obesity & Diabetes static version printer friendly pdf version
Competitor Analysis: PI3K-AKT-mTOR Inhibitors static version printer friendly pdf version
Competitor Analysis: Protein Kinase C (PKC) Inhibitors static version printer friendly pdf version
Competitor Analysis: Psoriasis static version printer friendly pdf version
Competitor Analysis: PTH Receptor Agonists static version printer friendly pdf version
Competitor Analysis: Ras-Raf-MEK-ERK Inhibitors static version printer friendly pdf version
Competitor Analysis: Systemic Lupus Erythematosus (SLE) static version printer friendly pdf version
Competitor Analysis: TGF-R Agonists and Antagonists static version printer friendly pdf version
Competitor Analysis: TNF Antagonists & Agonists static version printer friendly pdf version
Competitor Tracking, Customer Acquisition in the German Major Power Us... static version printer friendly
Complementary and Alternative Medicines in the United States 2008 static version printer friendly pdf version
Complementary and alternative therapies in cancer static version | |